Dr Kenneth Cutbush | Freeing Frozen Shoulders: The 360° Release

Nov 7, 2024 | Medical & Health Sciences

A frozen shoulder can significantly impact a person’s well-being. The constant pain and ongoing stiffness can sometimes only be relieved with surgery. Expert orthopaedic surgeon Dr Kenneth Cutbush from St Andrew’s War Memorial Hospital in Brisbane, Australia, works tirelessly to help ease the suffering of patients with various shoulder problems. Alongside colleagues, he pioneers a minimally invasive surgical technique, the frozen shoulder 360° release.

Living with a Frozen Shoulder

A frozen shoulder, also known as shoulder contracture or adhesive capsulitis, causes pain and stiffness. The pain is often far worse at night, interfering with sleep. The pain can get so intense that it is difficult for sufferers to move their arm and shoulder, and the affliction can last anywhere from a few months to several years. Treatments include painkillers and anti-inflammatory medication, steroid injections to reduce swelling in the shoulder joint, and physiotherapy.

Generally, the condition will eventually resolve independently, given enough time. However, many patients continue to suffer some restriction of movement. There is hope for such patients, as an operation can be carried out to release the joint. However, there are a variety of surgical techniques available to achieve this. Dr Kenneth Cutbush holds a Shoulder Clinic at the St Andrew’s War Memorial Hospital, helping patients find relief from their challenging shoulder joint conditions. Alongside colleagues, he researches orthopaedic surgery at both Queensland University of Technology’s Queensland Unit for Advanced Shoulder Research (QUASR) and the University of Queensland. The team have refined a surgical technique called the 360° release.

Safe and Reliable

Dr Cutbush highlights that it is often unclear why people end up with a frozen shoulder. Sometimes, it can happen after an injury or a period of reduced mobility, for example, post-surgery. It is characterised by inflammation of the soft tissues and membranes that form a protective capsule around the joint. These tissues can then tighten and shrink, causing pain and restriction of movement. Scar tissue can form, further impacting the range of motion of the shoulder joint.

Frozen shoulder surgery aims to release these capsular tissues, improving range of motion and easing pain. Dr Cutbush uses a minimally invasive surgery technique called arthroscopy, where a small camera is used to see inside the problematic joint. The arthroscope is inserted through a tiny incision, and he can view the camera feed on a monitor. Repairs can then be performed using specialist instruments via additional small incisions around the shoulder joint. Dr Cutbush says this procedure, known as an arthroscopic capsular release, is emerging as a safe and reliable operation for treating severe frozen shoulder in patients with significant loss of range of motion.

Surgical Complications

Dr Cutbush explains that even though frozen shoulder is a self-limited condition that resolves in most patients, about 40% to 60% of patients suffer some persisting restriction of motion. Although surgery is a treatment option for those with severe, debilitating symptoms, it is not without risk. The surgery itself can result in further damage to the joint, and the amount of release achieved can vary. He adds that earlier surgical techniques generally involved only a partial release of the shoulder capsule, as many surgeons were concerned that a more extensive release could result in complications, like making the joint less stable.

Dr Cutbush has many years of experience carrying out extensive arthroscopic frozen shoulder release surgeries. In a recent paper, along with colleagues, he describes a reproducible surgical technique for a 360° release, which he found to be safe, reliable, and with a very high patient satisfaction score. He says that even though extensive techniques such as this have always been thought to have a high rate of complications, none occurred for his cohort of patients.

The Frozen Shoulder 360° Release

The 360° arthroscopic capsular release previously carried out with the patient in the lateral decubitus position is performed with the patient in a reclined beach chair position. This entails the patient lying face up with them sitting up at a 30° angle. The arm is held in an arm positioner by the patient’s side and flexed forward 20° with inline traction. Two portals are created to insert the arthroscopic instruments, one anterior (at the front of the shoulder) and one posterior (at the back of the shoulder).

The procedure involves seven main steps, starting with placing the arthroscope through the posterior portal to give a view inside the joint. The front part of the shoulder capsule is then released via the anterior portal using an instrument called a straight arthroscopic punch. The shoulder capsule continues to be released all the way around, ending with the arthroscope switching portals, with a view from the anterior portal and the punch being carried out from the posterior portal.

Dr Cutbush explains that the reclined beach chair positioning and the traction arrangement used allow for the full-thickness capsular release to be more easily achieved and make it straightforward to view and access certain areas of the inferior capsule of the shoulder joint, as well as minimise the risk of nerve damage. The very reclined 30° positioning also helps reduce the risk of blood flow problems to the brain during the operation, minimising the likelihood of neurological injuries, compared to the traditional ‘beach chair’ positioning of the patient, where they sit up a lot further.

High Patient Satisfaction

Dr Cutbush says that the arthroscopic capsular release was previously considered quite a risky option due to the possibility of complications, particularly for a condition that often resolves on its own if given enough time. Partial capsular releases were generally more accepted as it was thought that more extensive releases were likely to have higher rates of complications. However, Dr Cutbush’s findings highlight that this may not be the case.

Dr Cutbush and his colleagues advocate the arthroscopic 360° capsular release as a safe and reliable method to achieve complete release of the shoulder capsule. Dr Cutbush adds that it is an option for those patients with debilitating restrictions caused by the contracture, shrinking and tightening of the shoulder capsular tissue, which limits the external rotation of the shoulder joint to less than 30°. His group of patients did not experience any complications, suggesting that the procedure is safe, and they were very satisfied with the outcome of the surgery, bringing fresh hopes for the treatment of this painful condition.

SHARE

DOWNLOAD E-BOOK

REFERENCE

https://doi.org/10.33548/SCIENTIA1127

MEET THE RESEARCHER


Dr Kenneth Cutbush
St Andrew’s Specialist Suites, St Andrew’s War Memorial Hospital, Brisbane, Queensland, Australia

Dr Kenneth Cutbush obtained his medical degree from the University of Queensland. He undertook much of his training at the Princess Alexandra Hospital, where he received the Gordon-Taylor Medal. He completed his postgraduate Orthopaedic Fellowship training at the Princess Alexandra Hospital in Hand and Upper Limb Surgery. Dr Cutbush is actively involved in research, having published numerous academic papers in international scientific journals, and is regularly invited to speak at surgical conferences worldwide. He was awarded the Shoulder and Elbow Society of Australia International Travelling Fellowship and is a corresponding member of the European Shoulder and Elbow Society (SECEC). He is closely involved in training surgeons and is the Chief Supervisor of three Australian Orthopaedic Association (AOA) accredited Fellowships in Shoulder Arthroscopy and Arthroplasty. In 2016, he was appointed Associate Professor at the University of Queensland, and in 2022, Adjunct Professor at the Queensland University of Technology. He currently holds several prestigious positions, including Scientific Secretary and Board member of the Australian Orthopaedic Association (AOA). Dr Cutbush’s current work focuses on shoulder surgery, such as arthroscopic release for patients with severely frozen shoulders, and he holds a clinic at St Andrew’s War Memorial Hospital.

CONTACT

E: ken@kennethcutbush.com

W: www.kennethcutbush.com

X: X.com/KennethCutbush

Facebook: facebook.com/kenneth.cutbush

LinkedIn: LinkedIn.com/in/shoulder-surgeon-brisbane/

KEY COLLABORATORS

Prof Ashish Gupta, Dr Kristine Italia, Dr Rishi Narasimhan

FURTHER READING

K Cutbush, K Italia, R Narasimhan, A Gupta, Frozen Shoulder 360° Release, Arthroscopy Techniques, 2021, 10(4), e963–e967. DOI: https://doi.org/10.1016/j.eats.2020.11.006

REPUBLISH OUR ARTICLES

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence (CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

SUBSCRIBE NOW


Follow Us

MORE ARTICLES YOU MAY LIKE

Dr Hatim Hassan | Proteins identified in gut bacteria that reduce oxalate levels

Dr Hatim Hassan | Proteins identified in gut bacteria that reduce oxalate levels

New research has identified proteins from gut bacteria, called Sel1-like proteins, that have the potential to help the body get rid of excess oxalate, an organic substance linked to kidney stones, kidney disease, and other health problems. Sel1-like proteins help the cell in assembling large molecular complexes important for cell function. Dr Hatim Hassan from the Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States, is part of a team of scientists researching whether these proteins and their derived peptides could reduce blood and urinary oxalate levels to prevent and/ or treat hyperoxalemia (high blood oxalate), hyperoxaluria (high urine oxalate) and related disorders (including kidney stones).

Dr Norio Mitsuhashi | Measuring Respiratory Motion to Improve Precision in Lung Radiation Therapy

Dr Norio Mitsuhashi | Measuring Respiratory Motion to Improve Precision in Lung Radiation Therapy

Dr Norio Mitsuhashi, former Professor of the Department of Radiation Oncology at Tokyo Women’s Medical University, leads revolutionary clinical research into optimising stereotactic body radiation therapy for lung cancer. Dr Mitsuhashi and his colleagues examine whether routinely available patient and tumour characteristics can predict respiratory tumour motion, a critical source of uncertainty in high precision radiotherapy. Their findings suggest that respiratory motion cannot be reliably inferred, and must instead be measured directly in every patient.

Professor Terry C. Hrubec | Clean is good – but is too clean better?

Professor Terry C. Hrubec | Clean is good – but is too clean better?

Quaternary ammonium compounds are a large class of compounds used as disinfectants in hospitals, restaurants, healthcare and animal care facilities, and are popular as household cleaners. With disease outbreaks increasing our fears about infections, the use of disinfectants has skyrocketed in recent years. Understandably, we all want to feel safe. However, as Professor Terry Hrubec from the Department of Biomedical Sciences of E. Via College of Osteopathic Medicine discovered, such products may be causing more harm than good.

Professor Abraham P. Lee | Delivering Cancer Immunotherapy with Acoustic-Electric Precision, AESOP’s Fact not Fable

Professor Abraham P. Lee | Delivering Cancer Immunotherapy with Acoustic-Electric Precision, AESOP’s Fact not Fable

Chimeric Antigen Receptor (CAR) T-cell therapy offers life-saving potential, particularly against blood cancers, but severe side effects such as cytokine release syndrome (CRS) limit its safety. These toxicities are linked to uncontrolled CAR expression levels on the T-cell surface. Led by Professor Abraham P. Lee, researchers at the University of California, Irvine, have developed an advanced microfluidic system, called the Acoustic-Electric Shear Orbiting Poration (AESOP) platform, to precisely control the dose of genetic material delivered into primary T cells. This innovation promises safer, more homogeneous, and highly effective cellular immunotherapies.